D. Daydé

Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20.

A. le Pape, G. Paintaud, S. Lerondel, 2009, Blood.

ZEBRA cell‐penetrating peptide as an efficient delivery system in Candida albicans

J. Lenormand, R. Marchione, M. Cornet, 2014, Biotechnology journal.

Hybrid gadolinium oxide nanoparticles combining imaging and therapy

Olivier Tillement, Marc Janier, Stéphanie Lerondel, 2009 .

Feasibility of a prehabilitation programme dedicated to older patients with cancer before complex medical–surgical procedures: the PROADAPT pilot study protocol

B. Riche, V. Pitiot, C. Falandry, 2021, BMJ Open.

Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.

M. Pallardy, S. Loisel, C. Berthou, 2007, Critical reviews in oncology/hematology.

Cultural and Ethical Barriers to Cancer Treatment in Nursing Homes and Educational Strategies: A Scoping Review

Arnaud Simeone, C. Falandry, Christine Ravot, 2021, Cancers.

Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol

É. Gadéa, A. Friggeri, L. Argaud, 2021, BMJ Open.